Skip to main content

Table 6 Univariate Cox proportional hazard analysis (disease-free survival) in the oestrogen-receptor-negative cohort

From: Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours

Variable Evaluation Hazard ratio (95% confidence interval) P value
Tumour size T1 (≤ 2 mm) 1  
  T2 (2 < T ≤ 5 mm) 1.45 (0.40 to 5.21) 0.567
  T3 (>5 mm) 3.57 (0.88 to 14.4) 0.073
Lymph node stage Negative 1  
  1 to 3 lymph nodes 0.47 (0.10 to 2.16) 0.338
  >3 lymph nodes 2.49 (1.02 to 6.03) 0.044
Tumour grade Grade I a  
  Grade II 1  
  Grade III 2.85 (1.05 to 7.57) 0.040
HER-2/neu expression HER-2/neu-negative 1  
  HER-2/neu-positive 2.04 (0.90 to 4.61) 0.086
FOXA1 expression FOXA1-positive 1  
  FOXA1-negative 3.61 (0.83 to 15.60) 0.086
GATA-3 expression GATA-3-positive 1  
  GATA-3-negative 1.53 (0.44 to 5.28) 0.495
  1. FOXA-1, forkhead box A1; GATA-3, GATA binding protein 3; HER-2, human epidermal growth factor receptor 2. aThere were no oestrogen-receptor-negative cases classified as grade I among the patients with available follow-up information.